| 10/13/2026 4:30 PM | Cadrenal Therapeutics (1937993) Issuer WILSON GLYNN (1405625) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/13/2026 4:32 PM | Cadrenal Therapeutics (1937993) Issuer Cole Jeffrey Scott (1751100) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/13/2026 4:32 PM | Cadrenal Therapeutics (1937993) Issuer MURPHY JOHN RAYMOND (1275195) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/13/2026 4:33 PM | Cadrenal Therapeutics (1937993) Issuer Golden Lee Scott (1686217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/13/2026 4:33 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/08/2026 4:07 PM | Cadrenal Therapeutics (1937993) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 10/07/2026 8:23 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/29/2026 3:05 PM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/03/2026 4:15 PM | Cadrenal Therapeutics (1937993) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/31/2026 7:29 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2026 3:30 PM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CVKD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 08/13/2026 3:31 PM | Cadrenal Therapeutics (1937993) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/07/2026 7:11 AM | Cadrenal Therapeutics (1937993) Subject PNC FINANCIAL SERVICES GROUP, INC. (713676) Filed by | Form SCHEDULE 13G | |
| 08/03/2026 4:09 PM | Cadrenal Therapeutics (1937993) Filer | Form DEF 14A | |
| 08/03/2026 4:11 PM | Cadrenal Therapeutics (1937993) Filer | Form ARS | |
| 08/03/2026 4:12 PM | Cadrenal Therapeutics (1937993) Filer | Form DEFA14A | |
| 07/23/2026 4:22 PM | Cadrenal Therapeutics (1937993) Filer | Form PRE 14A | |
| 07/21/2026 7:30 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/20/2026 11:15 PM | Cadrenal Therapeutics (1937993) Filer | Form EFFECT | |
| 07/20/2026 3:37 PM | Cadrenal Therapeutics (1937993) Filer | Form 424B3 | |
| 07/17/2026 3:15 PM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/15/2026 4:00 PM | Cadrenal Therapeutics (1937993) Filer | Form D Notice of Exempt Offering of Securities | |
| 07/13/2026 4:10 PM | Cadrenal Therapeutics (1937993) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 07/10/2026 3:05 PM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/01/2026 8:52 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 4:23 PM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/29/2026 4:19 PM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/26/2026 7:44 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2026 4:15 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 5:36 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 8:02 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/15/2026 7:58 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 7:16 PM | Cadrenal Therapeutics (1937993) Subject Pham Quang X (1405290) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/10/2026 7:26 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2026 4:26 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 7:34 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 3:30 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 8:06 PM | Cadrenal Therapeutics (1937993) Issuer Pham Quang X (1405290) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/07/2026 7:30 AM | Cadrenal Therapeutics (1937993) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 7:35 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/30/2026 7:40 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
A $247 tool for $7 (Ad) Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install.
The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years. See the Instant Scanner in action and claim the $7 Black Friday deal today. |
| 04/29/2026 11:15 PM | Cadrenal Therapeutics (1937993) Filer | Form EFFECT | |
| 04/29/2026 4:29 PM | Cadrenal Therapeutics (1937993) Filer | Form 424B3 | |
| 04/20/2026 6:55 PM | Cadrenal Therapeutics (1937993) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 04/01/2026 6:40 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 6:30 AM | Cadrenal Therapeutics (1937993) Filer | Form 424B5 | |
| 03/31/2026 7:55 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 8:02 AM | Cadrenal Therapeutics (1937993) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/12/2026 7:05 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/24/2026 7:35 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/02/2026 3:05 PM | Cadrenal Therapeutics (1937993) Filer | Form 424B3 | |
| 01/01/2026 11:15 PM | Cadrenal Therapeutics (1937993) Filer | Form EFFECT | |
| 12/31/2025 3:25 PM | Cadrenal Therapeutics (1937993) Filer | Form D Notice of Exempt Offering of Securities | |
| 12/31/2025 3:05 PM | Cadrenal Therapeutics (1937993) Issuer Szot Matthew K (1401385) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/29/2025 3:25 PM | Cadrenal Therapeutics (1937993) Subject Szot Matthew K (1401385) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/23/2025 8:27 PM | Cadrenal Therapeutics (1937993) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/23/2025 3:56 PM | Cadrenal Therapeutics (1937993) Filer | Form 424B5 | |
| 12/23/2025 3:58 PM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/16/2025 7:24 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/16/2025 7:18 AM | Cadrenal Therapeutics (1937993) Filer | Form 424B5 | |
| 12/16/2025 7:21 AM | Cadrenal Therapeutics (1937993) Filer | Form 424B5 | |
| 12/11/2025 7:17 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/03/2025 7:07 PM | Cadrenal Therapeutics (1937993) Issuer Golden Lee Scott (1686217) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 12/03/2025 7:08 PM | Cadrenal Therapeutics (1937993) Issuer Golden Lee Scott (1686217) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/01/2025 8:05 AM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/18/2025 3:20 PM | Cadrenal Therapeutics (1937993) Filer | Form 424B5 | |
| 11/18/2025 3:23 PM | Cadrenal Therapeutics (1937993) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |